BRPI0411702B8 - uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral - Google Patents

uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral

Info

Publication number
BRPI0411702B8
BRPI0411702B8 BRPI0411702A BRPI0411702A BRPI0411702B8 BR PI0411702 B8 BRPI0411702 B8 BR PI0411702B8 BR PI0411702 A BRPI0411702 A BR PI0411702A BR PI0411702 A BRPI0411702 A BR PI0411702A BR PI0411702 B8 BRPI0411702 B8 BR PI0411702B8
Authority
BR
Brazil
Prior art keywords
thrush
treatment
hyaluronic acid
oral cavity
prepare compositions
Prior art date
Application number
BRPI0411702A
Other languages
English (en)
Inventor
Franco Macchi
Original Assignee
Bioplax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30131290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0411702(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioplax Ltd filed Critical Bioplax Ltd
Publication of BRPI0411702A publication Critical patent/BRPI0411702A/pt
Publication of BRPI0411702B1 publication Critical patent/BRPI0411702B1/pt
Publication of BRPI0411702B8 publication Critical patent/BRPI0411702B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral". a presente invenção refere-se ao uso de ácido hialurônico como um único ingrediente ativo para a preparação de composições para uso tópico no tratamento de aftas da cavidade oral.
BRPI0411702A 2003-06-25 2004-06-23 uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral BRPI0411702B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001291A ITMI20031291A1 (it) 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
PCT/EP2004/051209 WO2005000321A1 (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas

Publications (3)

Publication Number Publication Date
BRPI0411702A BRPI0411702A (pt) 2006-08-08
BRPI0411702B1 BRPI0411702B1 (pt) 2019-08-13
BRPI0411702B8 true BRPI0411702B8 (pt) 2021-05-25

Family

ID=30131290

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411702A BRPI0411702B8 (pt) 2003-06-25 2004-06-23 uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral

Country Status (17)

Country Link
US (1) US10245280B2 (pt)
EP (1) EP1638582B1 (pt)
JP (1) JP4728955B2 (pt)
CN (1) CN1812798B (pt)
AT (1) ATE422892T1 (pt)
BR (1) BRPI0411702B8 (pt)
CA (1) CA2529441C (pt)
CY (1) CY1108992T1 (pt)
DE (1) DE602004019528D1 (pt)
DK (1) DK1638582T3 (pt)
ES (1) ES2322060T3 (pt)
IT (1) ITMI20031291A1 (pt)
MX (1) MXPA05014184A (pt)
PL (1) PL1638582T3 (pt)
PT (1) PT1638582E (pt)
SI (1) SI1638582T1 (pt)
WO (1) WO2005000321A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050142208A1 (en) * 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
ITMI20081450A1 (it) * 2008-08-04 2010-02-05 Biofarmitalia Spa Pellicola solida a rapida dissoluzione nei liquidi
IT1396468B1 (it) * 2008-11-11 2012-12-14 Farma Derma Srl Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie.
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP5840107B2 (ja) * 2012-06-17 2016-01-06 コスメディ製薬株式会社 ヒアルロン酸ゲル及びその製造方法
CN103860526A (zh) * 2013-11-26 2014-06-18 华熙福瑞达生物医药有限公司 一种含透明质酸的消毒剂、其制备方法及用途
EP3056195A1 (en) 2015-02-13 2016-08-17 Vision:Organic GmbH Compositions comprising hyaluronic acid and beta-glucan for topical applications in oral cavity
ITUB20153699A1 (it) * 2015-09-17 2017-03-17 Fastmeditalia Srl Integratore orale
IT201700048750A1 (it) * 2017-05-05 2018-11-05 Farm Procemsa S P A Composizione per il trattamento di afte e ulcere buccali
GB201713362D0 (en) * 2017-08-21 2017-10-04 Givaudan Sa Improvements in or relating to organic compounds
CN108210689A (zh) * 2017-11-27 2018-06-29 南京天纵易康生物科技股份有限公司 一种含有透明质酸的口腔溃疡膜剂及其制备方法
EP4230212A1 (en) 2022-02-16 2023-08-23 UNIVERSITÄTSmedizin der Johannes Gutenberg- Universität Mainz Composition and kits for the prevention or treatment of gum diseases
IT202200010439A1 (it) * 2022-05-19 2023-11-19 Anatek Health Italia S R L Composizione comprendente acido nevronico e beta-cariofillene nel trattamento della mucosite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US183278A (en) 1876-10-17 Improvement in ventilating-cowls
IT1240316B (it) 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
US5972906A (en) 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
US6828308B2 (en) 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.

Also Published As

Publication number Publication date
PL1638582T3 (pl) 2009-07-31
CY1108992T1 (el) 2014-07-02
DK1638582T3 (da) 2009-05-18
ES2322060T3 (es) 2009-06-16
CA2529441C (en) 2012-12-04
MXPA05014184A (es) 2006-03-09
CA2529441A1 (en) 2005-01-06
US10245280B2 (en) 2019-04-02
ITMI20031291A1 (it) 2004-12-26
EP1638582B1 (en) 2009-02-18
JP4728955B2 (ja) 2011-07-20
ITMI20031291A0 (it) 2003-06-25
WO2005000321A1 (en) 2005-01-06
BRPI0411702A (pt) 2006-08-08
SI1638582T1 (sl) 2009-10-31
PT1638582E (pt) 2009-05-28
CN1812798B (zh) 2011-02-09
US20060147393A1 (en) 2006-07-06
ATE422892T1 (de) 2009-03-15
DE602004019528D1 (de) 2009-04-02
CN1812798A (zh) 2006-08-02
EP1638582A1 (en) 2006-03-29
BRPI0411702B1 (pt) 2019-08-13
JP2009513492A (ja) 2009-04-02

Similar Documents

Publication Publication Date Title
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
CA2910494C (en) Insulin-oligomer conjugates, formulations and uses thereof
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
MY143795A (en) Tetrahydropyridoindole derivatives
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
ECSP055820A (es) Unidad para dosificación diaria de melatonina
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
SV2004001418A (es) Formulaciones farmaceuticas de 5,7,14-triazaciclo 10.3.1.0.2,11.04,9) -hexadeca-2(11),3,5,7,9-pentaeno" ref.pc 23248
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
ITMI20030195A1 (it) Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
SI1893237T1 (sl) Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
BR0207077A (pt) Sais de adição do ácido málico da terbinafina
BR0214644A (pt) Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação
BRPI0414454A (pt) agentes antibacterianos
NO20072090L (no) Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II
CY1110563T1 (el) Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/08/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/08/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/06/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2728 DE 18-04-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.